Laropiprant

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0571170-77-9

Chemical Formula

C21-H19-Cl-F-N-O4-S

Molecular Weight

435

Therapeutic Categories

Inhibitor of nicotinic acid-induced flushing

Selective prostaglandin D2 receptor 1 antagonist (DP1 receptor antagonist)

Chemical Names

[(3R)-4-[(4-Chlorophenyl)methyl]-7-fluoro-5-(methanesulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid (WHO)

Cyclopent[b]indole-3-acetic acid, 4-[(4-chlorophenyl)methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-, (3R)- (USAN)

Foreign Names

• Laropiprantum (Latin)
• Laropiprant (German)
• Laropiprant (French)
• Laropiprant (Spanish)

Generic Names

• Laropiprant (OS: USAN)
• MK-0524 (IS)
• UNII-G7N11T8O78 (IS)

Brand Names

• Tredaptive (Laropiprant and Nicotinic Acid)
  Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Germany; Merck Sharp & Dohme, Spain; Merck Sharp & Dohme, United Kingdom; Merck Sharp & Dohme, Ireland; Merck Sharp & Dohme, Sweden; MSD, Switzerland

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.